T1	Participants 1301 1324	Patients in both groups
T2	Participants 783 830	Twenty-two head and neck cancer patients from U
T3	Participants 1706 1713	Patient
T4	Participants 2074 2103	Patients in the control group
T5	Participants 2887 2941	study population associated with minimal complications
